Evidence map›Paper›PMID 29556122›Full record

ArticleSaudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society2018

Phenolic compounds from

Michelle Nonato de Oliveira Melo, Adriana Passos Oliveira, Adalgisa Felippe Wiecikowski, Renato Sampaio Carvalho, Juliana de Lima Castro, Felipe Alves Gomes de Oliveira, Henrique Marcelo Gualberto Pereira, Venicio Feo da Veiga, Marcia Marques Alves Capella, Leandro Rocha and 1 more

Open access · hybridAbstract read
In one paragraph

Article in Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 1 synthesis or guideline pooled it, 68 citations in OpenAlex.

  1. Pooled it
  2. Frontiers in physiology · 2025
    Article
  3. Immune Checkpoint Blockade Combined with AbnobaViscumPharmaceuticals (Basel, Switzerland) · 2024
    Article
  4. Review
  5. Article
  6. Green Synthesis of Zinc Oxide Nanoparticles UsingPlants (Basel, Switzerland) · 2023
    Article
  7. Article
  8. A Scoping Review of GenusPlants (Basel, Switzerland) · 2023
    Article
  9. Review
  10. PluronicPharmaceutics · 2022
    Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Frontiers in pharmacology · 2022
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Michelle Nonato de Oliveira MeloMultidisciplinary Laboratory of Pharmaceutical Sciences, Faculty of Pharmacy, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
Adriana Passos OliveiraMultidisciplinary Laboratory of Pharmaceutical Sciences, Faculty of Pharmacy, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
Adalgisa Felippe WiecikowskiDepartment of Pharmaceutical Biotechnology, Faculty of Pharmacy, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
Renato Sampaio CarvalhoDepartment of Pharmaceutical Biotechnology, Faculty of Pharmacy, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
Juliana de Lima CastroBrazilian Doping Control Laboratory, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
Felipe Alves Gomes de OliveiraBrazilian Doping Control Laboratory, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
Henrique Marcelo Gualberto PereiraBrazilian Doping Control Laboratory, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
Venicio Feo da VeigaMicroscopy Sector Professor Paulo de Góes, Microbiology Institute, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
Marcia Marques Alves CapellaMultidisciplinary Laboratory of Pharmaceutical Sciences, Faculty of Pharmacy, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
Leandro RochaDepartment of Pharmaceutical Technology, Faculty of Pharmacy, Fluminense Federal University, Niterói, RJ, Brazil.
Carla HolandinoMultidisciplinary Laboratory of Pharmaceutical Sciences, Faculty of Pharmacy, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
Universidade Federal do Rio de Janeiro · BRUniversidade Federal Fluminense · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cancer is one of the biggest problems in public health worldwide. Plants have been shown important role in anticancer research.

Indexed as

AntitumoralDMEM, Dulbecco’s Modified Eagle MediumHPLC, high performance liquid chromatographyHRMS, high resolution massLignansMistletoeNP/PEG, Diphenylboriloxyethilamine/polyetileneglicolPDA, photodiode array detectorPhenolic compoundsTA, tincture ATB, tincture BTLC, Thin Layer ChromatographyUFLC, ultra fast liquid chromatographyUHPLC, ultra high performance liquid chromatographyViscum album% v/v, % volume/volume

Identifiers

PMID29556122
PMCPMC5856955
OpenAlexW2792845290

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.